Screener
Maze Therapeutics MAZE Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 48,035 | 36,474 | 94,588 | 71,875 |
| Loss from operations | (48,035) | (36,474) | (74,588) | (71,875) |
| Other income (expense): | ||||
| Interest and other income, net | 4,239 | 2,795 | 7,450 | 5,410 |
| Interest expense | (931) | — | (1,797) | — |
| Total other income, net | 3,308 | 2,795 | 5,653 | 5,410 |
| Net loss | $(44,727) | $(33,679) | $(68,935) | $(66,465) |
| Net loss per share, basic and diluted: | $(0.76) | $(0.77) | $(1.22) | $(1.83) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Maze Therapeutics's interest income?
- Maze Therapeutics (MAZE) reported interest income of $4.24M in Q2 2026.
- How has Maze Therapeutics's interest income changed year-over-year?
- Maze Therapeutics's interest income increased by 51.7% year-over-year, from $2.8M to $4.24M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Maze Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude